Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol (original) (raw)

Abstract

Purpose

Uptake in brown adipose tissue (hibernating fat) is sometimes seen at FDG-PET examinations. Despite a characteristic appearance, this may hide clinically relevant uptake. Stimulation of the sympathetic nervous system increases glucose uptake of brown fat. We now re-examine patients with brown fat activity that could disguise tumour uptake after pre-treatment with propranolol (a non-selective β-blocker) in order to reduce the uptake. Our first examinations of this kind are reported.

Methods

Eleven patients with strong brown fat uptake were studied. There was a mean of 5 days (range 2–8) between the examinations. At the second examination, 80 mg of propranolol was given orally 2 h before FDG administration. In addition to visual evaluation of the brown fat uptake, SUV assessments of the uptake in brown fat, lung, heart, liver, spleen and bone marrow were made.

Results

All patients showed complete or almost complete disappearance of the brown fat activity at the second examination (p < 0.001) both upon visual evaluation and when comparing SUVs. In seven patients there was also uptake in a known or strongly suspected malignancy, which remained unchanged between the examinations. Beyond an insignificant decrease in the myocardial uptake, there was no redistribution to the various examined organs at the second examination.

Conclusion

Pre-treatment with a single dose of propranolol blocks the FDG uptake in brown adipose tissue, thereby increasing the specificity of the examination. The tumour uptake seems not to be impaired.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jacobsson H, Bruzelius M, Larsson SA. Reduction of FDG uptake in brown adipose tissue by propranolol. Eur J Nucl Med Mol Imaging 2005;32:1130.
    Article PubMed Google Scholar
  2. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 2002;29:1393–8.
    Article PubMed Google Scholar
  3. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat (“USA-fat”): description on 18F-FDG PET/CT. J Nucl Med 2003;44:170–6.
    PubMed CAS Google Scholar
  4. Yeung HW, Grewal RK, Gonen M, Schöder H, Larson SM. Patterns of 18F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 2003;44:1789–96.
    PubMed Google Scholar
  5. Truong MT, Erasmus JJ, Munden RF, Marom EM, Sabloff BS, Gladish GW, et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR 2004;183:1127–32.
    PubMed Google Scholar
  6. Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL. Intense 18F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 2004;45:1189–93.
    PubMed CAS Google Scholar
  7. Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;26:308–14.
    Article PubMed CAS Google Scholar
  8. Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 1996;37:1127–9.
    PubMed CAS Google Scholar
  9. Christensen CR, Clark PB, Morton KA. Reversal of hypermetabolic brown adipose tissue on FDG PET [abstract]. J Nucl Med 2005;46(Suppl):S41.
    Google Scholar
  10. Truong MT, Erasmus JJ, Macapinlac HA, Marom EM, Mawlawi O, Gladish GW, et al. Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer. Normal variants and pitfalls. J Comput Assist Tomogr 2005;29:205–9.
    Article PubMed Google Scholar
  11. Hull D, Segall M. Sympathetic nervous control of brown adipose tissue and heat production in the new-born rabbit. J Physiol 1965;181:458–67.
    PubMed CAS Google Scholar
  12. Cohade C, Mourtzikos KA, Wahl RL. “USA-fat”: prevalence is related to ambient outdoor temperature—evaluation with 18F-FDG PET/CT. J Nucl Med 2003;44:1267–70.
    PubMed Google Scholar
  13. Rousseau C, Bourbouloux E, Campion L, Fleury N, Bridji B, Chatal JF, et al. Brown fat in breast cancer patients: analysis of serial 18F-FDG PET/CT scans. Eur J Nucl Med Mol Imaging 2006;33:785–91.
    Article PubMed CAS Google Scholar

Download references

Acknowledgements

Advice from Dr. Hans Johnsson, Department of Internal Medicine, Karolinska University Hospital and the statistical analysis by Elisabeth Berg, BSc, Medical Statistics Unit, Karolinska Institute, are greatly appreciated.

Author information

Authors and Affiliations

  1. Department of Radiology, Karolinska University Hospital, 171 76, Stockholm, Sweden
    Veli Söderlund & Hans Jacobsson
  2. Department of Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden
    Stig A. Larsson & Hans Jacobsson

Authors

  1. Veli Söderlund
    You can also search for this author inPubMed Google Scholar
  2. Hans Jacobsson
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toVeli Söderlund.

Rights and permissions

About this article

Cite this article

Söderlund, V., Larsson, S.A. & Jacobsson, H. Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol.Eur J Nucl Med Mol Imaging 34, 1018–1022 (2007). https://doi.org/10.1007/s00259-006-0318-9

Download citation

Keywords